Breakthrough study: inhibiting USP30 gene offers hope in treating Parkinson’s disease Post author: Post published: November 15, 2023 Post category:uncategorized Whether USP30 inhibition can serve as a disease-modifying therapy for Parkinson’s disease (PD). You Might Also Like Can drones become the frontline of medical delivery in flood-hit regions? October 12, 2025 Liposomal bupivacaine shows no advantage in postoperative pain management for older adults September 19, 2024 NIH awards $1 million five-year grant to study the genetics of cataracts in children June 10, 2026
Liposomal bupivacaine shows no advantage in postoperative pain management for older adults September 19, 2024